Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
Clinical trial NCT00200525 · COMPLETED
Trial details
- NCT number
- NCT00200525
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.